Ganciclovir use during mild renal failure in heart transplantation. - Suppr | 超能文献

Ganciclovir use during mild renal failure in heart transplantation.

作者信息

Bastien O, Boulieu R, Bleyzac N, Boissonnat P, Garre J P, Dureau G

机构信息

Hôpital Cardiologique et Pneumologique L. Pradel, Lyon, France.

出版信息

Transplant Proc. 1996 Oct;28(5):2876-7.

Abstract

摘要

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1

Ganciclovir use during mild renal failure in heart transplantation.

Transplant Proc. 1996 Oct;28(5):2876-7.

2

Pharmacokinetics of ganciclovir in haematopoietic stem cell transplantation recipients with or without renal impairment.更昔洛韦在有或无肾功能损害的造血干细胞移植受者中的药代动力学

J Antimicrob Chemother. 2006 May;57(5):1004-7. doi: 10.1093/jac/dkl089. Epub 2006 Mar 21.

3

Preemptive therapy for cytomegalovirus infections and the development of resistance to ganciclovir.

J Infect Dis. 2002 Sep 1;186(5):724-5; author reply 725-6. doi: 10.1086/342394.

4

Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.口服更昔洛韦或口服阿昔洛韦预防器官移植受者原发性巨细胞病毒病

Transpl Infect Dis. 2000 Sep;2(3):112-7.

5

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation.口服更昔洛韦与口服伐昔洛韦预防肾移植后巨细胞病毒病的随机前瞻性对照试验。

Transpl Int. 2002 Dec;15(12):615-22. doi: 10.1007/s00147-002-0475-0. Epub 2002 Nov 5.

6

Ganciclovir.更昔洛韦

N Engl J Med. 1996 Sep 5;335(10):721-9. doi: 10.1056/NEJM199609053351007.

7

Randomized trial of daily versus three-times-weekly prophylactic ganciclovir after lung and heart-lung transplantation.肺移植和心肺移植后每日与每周三次预防性使用更昔洛韦的随机试验。

J Heart Lung Transplant. 1998 Sep;17(9):913-20.

8

Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus.

Clin Infect Dis. 2007 Aug 15;45(4):448-9. doi: 10.1086/519940. Epub 2007 Jul 10.

9

Cytomegalovirus infection in kidney transplantation: prophylaxis and management.

Transplant Proc. 1996 Dec;28(6):3310-1.

10

Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.口服伐昔洛韦与静脉注射更昔洛韦预防异基因骨髓移植后巨细胞病毒病的随机对照研究。

Clin Infect Dis. 2003 Mar 15;36(6):749-58. doi: 10.1086/367836. Epub 2003 Mar 3.

引用本文的文献

1

Valganciclovir in adult solid organ transplant recipients: pharmacokinetic and pharmacodynamic characteristics and clinical interpretation of plasma concentration measurements.伐昔洛韦在成人实体器官移植受者中的应用：药代动力学和药效学特征及血药浓度测定的临床解读。

Clin Pharmacokinet. 2009;48(6):399-418. doi: 10.2165/00003088-200948060-00006.